Osaic Holdings’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-175
| Closed | -$7.16K | – | 7383 |
|
|
2024
Q2 | $7.16K | Buy |
175
+95
| +119% | +$3.88K | ﹤0.01% | 5905 |
|
|
2024
Q1 | $3.38K | Buy |
80
+20
| +33% | +$845 | ﹤0.01% | 6131 |
|
|
2023
Q4 | $2.54K | Sell |
60
-60
| -50% | -$2.54K | ﹤0.01% | 6338 |
|
|
2023
Q3 | $2.62K | Buy |
120
+60
| +100% | +$1.31K | ﹤0.01% | 6422 |
|
|
2023
Q2 | $1.91K | Hold |
60
| – | – | ﹤0.01% | 6561 |
|
|
2023
Q1 | $1.46K | Sell |
60
-5
| -8% | -$122 | ﹤0.01% | 6724 |
|
|
2022
Q4 | $2K | Hold |
65
| – | – | ﹤0.01% | 6683 |
|
|
2022
Q3 | $2K | Sell |
65
-254
| -80% | -$7.82K | ﹤0.01% | 6786 |
|
|
2022
Q2 | $9K | Buy |
319
+39
| +14% | +$1.1K | ﹤0.01% | 6162 |
|
|
2022
Q1 | $10K | Buy |
280
+249
| +803% | +$8.89K | ﹤0.01% | 6112 |
|
|
2021
Q4 | $1K | Buy |
+31
| New | +$1K | ﹤0.01% | 7113 |
|